0000000000122987

AUTHOR

Philippe Allouch

showing 3 related works from this author

Late neointimal tissue growth behind the stent after intravascular gamma-radiation.

2003

To determine the nature of the changes of the vascular wall after intravascular brachytherapy in stented arteries leading to incomplete stent apposition.Stents were implanted in the infrarenal aortas of rabbits, and gamma-intravascular brachytherapy (18 Gy) or a sham radiation procedure was immediately implemented. The arteries were harvested at 6 months for histologic analyses.The external elastic lamina area, as well as the vascular wall area behind the stent, were significantly greater in irradiated vs. control arteries (8.94 +/- 0.68 mm2 vs. 6.87 +/- 0.40 mm2 [p0.001] and 1.56 +/- 0.13 mm2 vs. 0.72 +/- 0.07 mm2 [p0.001], respectively). The ratio of the intimal area behind the stent rela…

MaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyConstriction PathologicConstrictionRestenosismedicine.arterymedicineAnimalsRadiology Nuclear Medicine and imagingAorta AbdominalAortaRadiationγ radiationbusiness.industryStentIncomplete stent appositionmedicine.diseaseOncologyIntravascular brachytherapyGamma RaysStentsRadiologyRabbitsbusinessTunica IntimaInternational journal of radiation oncology, biology, physics
researchProduct

Intramural neovascularization and haemorrhages are major long‐term effects of intravascularγ‐radiation after stenting

2003

Structural changes that might influence the structural integrity of the vessel in response to intravascular brachytherapy (IVB) and stenting were examined, focus being on the importance of neovascularization in rabbit stented arteries. Stents were implanted in the infrarenal aortas of rabbits, immediately followed by gamma IVB or a sham radiation procedure, and the arteries harvested at 6 months. Labelling for von Willebrand factor showed an increase in adventitial and medial neovascularization in irradiated versus control arteries group (5.04+/-0.89 versus 1.51+/-0.23 mm(-2), respectively; p=0.004). Moreover, intramedial haemorrhages (free hemosiderin deposition) and inflammation (macropha…

MalePathologymedicine.medical_specialtyBrachytherapyHemorrhageInflammationMatrix metalloproteinaseCoronary RestenosisNeovascularizationHemosiderin DepositionVon Willebrand factorReference ValuesmedicineAnimalsRadiology Nuclear Medicine and imagingAorta AbdominalVascular Diseasesγ radiationNeovascularization PathologicRadiological and Ultrasound Technologybiologybusiness.industryStructural integrityIntravascular brachytherapyGamma RaysMetalloproteasesbiology.proteinStentsCollagenRabbitsmedicine.symptombusinessInternational Journal of Radiation Biology
researchProduct

Temporal Trends in Transcatheter Aortic Valve Replacement in France

2017

Background - Transcatheter aortic valve replacement (TAVR) is standard therapy for patients with severe aortic stenosis who are at high surgical risk. However, national data regarding procedural characteristics and clinical outcomes over time are limited. Objectives - The aim of this study was to assess nationwide performance trends and clinical outcomes of TAVR during a 6-year period. Methods - TAVRs performed in 48 centers across France between January 2013 and December 2015 were prospectively included in the FRANCE TAVI (French Transcatheter Aortic Valve Implantation) registry. Findings were further compared with those reported from the FRANCE 2 (French Aortic National CoreValve and Edwa…

Aortic valvemedicine.medical_specialtymedicine.medical_treatmentnational registry030204 cardiovascular system & hematologyoutcomes03 medical and health sciences0302 clinical medicineValve replacementCardiac tamponadeMedicine030212 general & internal medicineComputingMilieux_MISCELLANEOUSAortic dissectionbusiness.industryMortality ratetransfemoralEuroSCORE[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseasepacemaker3. Good healthSurgeryStenosisCathetermedicine.anatomical_structureCardiology and Cardiovascular Medicinebusiness
researchProduct